|
||||||||||||||||||||||
![]() |
|
![]() |
![]() |
|
![]() von Hippel-Lindau peptide vaccine A cancer vaccine composed of peptides derived from a tumor-associated protein encoded by a mutated Von Hippel-Lindau (VHL) oncogene. VHL peptide vaccine may stimulate a cytotoxic T cell response against tumor cells expressing the VHL tumor-associated protein. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus) ![]()
![]() ![]() ![]()
|
![]() |
![]() |
![]() |
![]() |
NCI Home |
Images Version |
Contact Us |
Policies |
Accessibility |
Viewing Files |
FOIA |
Site Help |
Site Map
|
![]() A Service of the National Cancer Institute |
![]() |
![]() |